Table of Contents

- M I Harris and
- R C Eastman
Is there a glycemic threshold for mortality risk?
Diabetes Care March 1998 21:331-333; doi:10.2337/diacare.21.3.331
- Full Text (PDF)
- J Wylie-Rosett
Efficacy of diet and exercise in reducing body weight and conversion to overt diabetes.
Diabetes Care March 1998 21:334-335; doi:10.2337/diacare.21.3.334
- Full Text (PDF)
Select this article
- T M Wolever,
- J L Chiasson,
- A Csima,
- J A Hunt,
- C Palmason,
- S A Ross,
- and E A Ryan
Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose.
Diabetes Care March 1998 21:336-340; doi:10.2337/diacare.21.3.336
- Abstract
- Full Text (PDF)
Select this article
- P King,
- M F Kong,
- H Parkin,
- I A Macdonald,
- and R B Tattersall
Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM.
Diabetes Care March 1998 21:341-345; doi:10.2337/diacare.21.3.341
- Abstract
- Full Text (PDF)
Select this article
- J Roumain,
- M A Charles,
- M P de Courten,
- R L Hanson,
- T D Brodie,
- D J Pettitt,
- and W C Knowler
The relationship of menstrual irregularity to type 2 diabetes in Pima Indian women.
Diabetes Care March 1998 21:346-349; doi:10.2337/diacare.21.3.346
- Abstract
- Full Text (PDF)
Select this article
- R R Wing,
- E Venditti,
- J M Jakicic,
- B A Polley,
- and W Lang
Lifestyle intervention in overweight individuals with a family history of diabetes.
Diabetes Care March 1998 21:350-359; doi:10.2337/diacare.21.3.350
- Abstract
- Full Text (PDF)
Select this article
- B Balkau,
- M Shipley,
- R J Jarrett,
- K Pyörälä,
- M Pyörälä,
- A Forhan,
- and E Eschwège
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study.
Diabetes Care March 1998 21:360-367; doi:10.2337/diacare.21.3.360
- Abstract
- Full Text (PDF)
Select this article
- L M Pogach,
- G Hawley,
- R Weinstock,
- C Sawin,
- H Schiebe,
- F Cutler,
- F Zieve,
- M Bates,
- and D Repke
Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994). Use of an ambulatory care pharmacy-derived database.
Diabetes Care March 1998 21:368-373; doi:10.2337/diacare.21.3.368
- Abstract
- Full Text (PDF)
Select this article
- A E Gold,
- C Reilly,
- and J D Walker
Transient improvement in glycemic control. The impact of pregnancy in women with IDDM.
Diabetes Care March 1998 21:374-378; doi:10.2337/diacare.21.3.374
- Abstract
Select this article
- E A Northam,
- P J Anderson,
- G A Werther,
- G L Warne,
- R G Adler,
- and D Andrewes
Neuropsychological complications of IDDM in children 2 years after disease onset.
Diabetes Care March 1998 21:379-384; doi:10.2337/diacare.21.3.379
- Abstract
- Full Text (PDF)
Select this article
- N Islam,
- F Kazmi,
- G D Chusney,
- M B Mattock,
- A Zaini,
- and J C Pickup
Ethnic differences in correlates of microalbuminuria in NIDDM. The role of the acute-phase response.
Diabetes Care March 1998 21:385-388; doi:10.2337/diacare.21.3.385
- Abstract
- Full Text (PDF)
Select this article
- W Rathmann,
- B Haastert,
- J M Roseman,
- F A Gries,
- and G Giani
Prescription drug use and costs among diabetic patients in primary health care practices in Germany.
Diabetes Care March 1998 21:389-397; doi:10.2337/diacare.21.3.389
- Abstract
- Full Text (PDF)
Select this article
- M Vanhanen,
- K Koivisto,
- J Kuusisto,
- L Mykkänen,
- E L Helkala,
- T Hänninen,
- P Riekkinen, Sr,
- H Soininen,
- and M Laakso
Cognitive function in an elderly population with persistent impaired glucose tolerance.
Diabetes Care March 1998 21:398-402; doi:10.2337/diacare.21.3.398
- Abstract
- Full Text (PDF)
Select this article
- P M Catalano,
- N M Drago,
- and S B Amini
Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance.
Diabetes Care March 1998 21:403-408; doi:10.2337/diacare.21.3.403
- Abstract
- Full Text (PDF)
Select this article
- P S Johnston,
- P U Feig,
- R F Coniff,
- A Krol,
- J A Davidson,
- and S M Haffner
Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients.
Diabetes Care March 1998 21:409-415; doi:10.2337/diacare.21.3.409
- Abstract
- Full Text (PDF)
Select this article
- P S Johnston,
- P U Feig,
- R F Coniff,
- A Krol,
- D E Kelley,
- and A D Mooradian
Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.
Diabetes Care March 1998 21:416-422; doi:10.2337/diacare.21.3.416
- Abstract
- Full Text (PDF)
Select this article
- M U Rarick,
- B M Espina,
- D T Colley,
- A Chrusoskie,
- S Gandara,
- and D I Feinstein
Treatment of a unique anemia in patients with IDDM with epoetin alfa.
Diabetes Care March 1998 21:423-426; doi:10.2337/diacare.21.3.423
- Abstract
- Full Text (PDF)
Select this article
- E Björk,
- C Berne,
- and F A Karlsson
Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide.
Diabetes Care March 1998 21:427-430; doi:10.2337/diacare.21.3.427
- Abstract
- Full Text (PDF)
Select this article
- R P Young,
- J C Chan,
- J A Critchley,
- E Poon,
- G Nicholls,
- and C S Cockram
Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients.
Diabetes Care March 1998 21:431-437; doi:10.2337/diacare.21.3.431
- Abstract
- Full Text (PDF)
Select this article
- S Cucchiara,
- A Franzese,
- G Salvia,
- L Alfonsi,
- V D Iula,
- A Montisci,
- and F L Moreira
Gastric emptying delay and gastric electrical derangement in IDDM.
Diabetes Care March 1998 21:438-443; doi:10.2337/diacare.21.3.438
- Abstract
- Full Text (PDF)
Select this article
- J Jaremko and
- O Rorstad
Advances toward the implantable artificial pancreas for treatment of diabetes.
Diabetes Care March 1998 21:444-450; doi:10.2337/diacare.21.3.444
- Abstract
- Full Text (PDF)
- N J Bohannon
Treatment of vulvovaginal candidiasis in patients with diabetes.
Diabetes Care March 1998 21:451-456; doi:10.2337/diacare.21.3.451
- Full Text (PDF)
- Z T Bloomgarden
American Diabetes Association Annual Meeting, 1997. Improvement of the quality of diabetes care.
Diabetes Care March 1998 21:457-460; doi:10.2337/diacare.21.3.457
- Full Text (PDF)
- A Lakhdar
The diagnosis of preexisting diabetes associated with acute myocardial infarction.
Diabetes Care March 1998 21:461; doi:10.2337/diacare.21.3.461b
- Full Text (PDF)
- L Heinemann,
- H Overmann,
- and I Mühlhauser
How well do patients with type 1 diabetes measure their blood glucose in daily life.
Diabetes Care March 1998 21:461-462; doi:10.2337/diacare.21.3.461a
- Full Text (PDF)
- C S Bartsocas
A word of caution on the use of lispro.
Diabetes Care March 1998 21:462; doi:10.2337/diacare.21.3.462b
- Full Text (PDF)
- R Weitgasser,
- I Kartnig,
- and C Baumann
Medicine and the media.
Diabetes Care March 1998 21:462; doi:10.2337/diacare.21.3.462a
- Full Text (PDF)
- M Broch,
- C Gutierrez,
- C Aguilar,
- I Simon,
- C Richart,
- and J Vendrell
Genetic variation in promoter (4G/5G) of plasminogen activator inhibitor 1 gene in type 2 diabetes. Absence of relationship with microangiopathy.
Diabetes Care March 1998 21:463; doi:10.2337/diacare.21.3.463b
- Full Text (PDF)
- D Chevenne,
- M Fonfrède,
- R Ducrocq,
- M Chauffert,
- and F Trivin
Uremia and HbA1c measured by high-performance liquid chromatography.
Diabetes Care March 1998 21:463-464; doi:10.2337/diacare.21.3.463a
- Full Text (PDF)
- R C Eastman
Cost-effectiveness of treatment of type 2 diabetes.
Diabetes Care March 1998 21:464-465; doi:10.2337/diacare.21.3.464
- Full Text (PDF)
- N Sakane,
- T Yoshida,
- A Kogure,
- and M Kondo
Different effects of acarbose and voglibose on serum 1,5-anhydroglucitol concentrations.
Diabetes Care March 1998 21:465-466; doi:10.2337/diacare.21.3.465
- Full Text (PDF)
- S S Fajans
Revised etiologic classification of diabetes.
Diabetes Care March 1998 21:466-467; doi:10.2337/diacare.21.3.466
- Full Text (PDF)
- E A Sims and
- P M Catalano
Response to the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
Diabetes Care March 1998 21:467-468; doi:10.2337/diacare.21.3.467
- Full Text (PDF)
- E Mannucci,
- G Bardini,
- A Ognibene,
- and C M Rotella
Screening for diabetes in obese patients using the new diagnostic criteria.
Diabetes Care March 1998 21:468-469; doi:10.2337/diacare.21.3.468
- Full Text (PDF)
- F J Service
New classification of diabetes.
Diabetes Care March 1998 21:469-470; doi:10.2337/diacare.21.3.469
- Full Text (PDF)
- M W Strachan and
- B M Frier
Risk of severe hypoglycemia in diabetes patients taking ACE inhibitors.
Diabetes Care March 1998 21:470; doi:10.2337/diacare.21.3.470b
- Full Text (PDF)
- N Chaturvedi and
- J H Fuller
ACE inhibitors and risk of hypoglycemia in people with diabetes.
Diabetes Care March 1998 21:470-472; doi:10.2337/diacare.21.3.470a
- Full Text (PDF)

Is there a glycemic threshold for mortality risk?

Efficacy of diet and exercise in reducing body weight and conversion to overt diabetes.

Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose.

Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM.

The relationship of menstrual irregularity to type 2 diabetes in Pima Indian women.

Lifestyle intervention in overweight individuals with a family history of diabetes.

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study.

Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994). Use of an ambulatory care pharmacy-derived database.

Transient improvement in glycemic control. The impact of pregnancy in women with IDDM.

Neuropsychological complications of IDDM in children 2 years after disease onset.

Ethnic differences in correlates of microalbuminuria in NIDDM. The role of the acute-phase response.

Prescription drug use and costs among diabetic patients in primary health care practices in Germany.

Cognitive function in an elderly population with persistent impaired glucose tolerance.

Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance.

Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients.

Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.

Treatment of a unique anemia in patients with IDDM with epoetin alfa.

Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide.

Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients.

Gastric emptying delay and gastric electrical derangement in IDDM.

Advances toward the implantable artificial pancreas for treatment of diabetes.

Treatment of vulvovaginal candidiasis in patients with diabetes.

American Diabetes Association Annual Meeting, 1997. Improvement of the quality of diabetes care.

The diagnosis of preexisting diabetes associated with acute myocardial infarction.

How well do patients with type 1 diabetes measure their blood glucose in daily life.

A word of caution on the use of lispro.

Medicine and the media.

Genetic variation in promoter (4G/5G) of plasminogen activator inhibitor 1 gene in type 2 diabetes. Absence of relationship with microangiopathy.

Uremia and HbA1c measured by high-performance liquid chromatography.

Cost-effectiveness of treatment of type 2 diabetes.

Different effects of acarbose and voglibose on serum 1,5-anhydroglucitol concentrations.

Revised etiologic classification of diabetes.

Response to the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Screening for diabetes in obese patients using the new diagnostic criteria.

New classification of diabetes.

Risk of severe hypoglycemia in diabetes patients taking ACE inhibitors.

ACE inhibitors and risk of hypoglycemia in people with diabetes.

This Issue

Current Issue

From the Cover